PhII ICb With/Without Erbitux in MBC Pts

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PhII ICb With/Without Erbitux in MBC Pts	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Phase 2	2025-01-29		NCT00248287

3 results · Page 1 of 1

Swipe the table sideways for more columns.

59 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Allison Cancer Center	Midland	United States	1
Arch Medical Services, Inc	St Louis	United States	1
Birmingham Hematology and Oncology	Birmingham	United States	1
Cancer Care Northwest-South	Spokane	United States	1
Cancer Center of the Carolinas, Seneca	Seneca	United States	1
Cancer Centers of Florida, P.A.	Ocoee	United States	1
Central Indiana Cancer Center	Indianapolis	United States	1
Comprehensive Cancer Centers of Nevada	Las Vegas	United States	1
El Paso Cancer Treatment Ctr	El Paso	United States	1
Florida Cancer Institute	New Port Richey	United States	1
Greater Dayton Cancer Center	Kettering	United States	126
Hematology Oncology Asscociates	Phoenix	United States	1
Hematology Oncology Associates of IL	Chicago	United States	1
Hematology-Oncology Associates of NNJ, P.A.	Morristown	United States	1
HOAST - New Braunfels	New Braunfels	United States	1
Interlakes Oncology Hematology, PC	Rochester	United States	1
Kansas City Cancer-Southwest	Overland Park	United States	1
Longview Cancer Center	Longview	United States	1
Mamie McFaddin Ward Cancer Center	Beaumont	United States	1
Maryland Oncology Hematology, P.A.	Columbia	United States	9
Melbourne Internal Medicine Associates	Melbourne	United States	1
Minnesota Oncology Hematology, P.A.	Minneapolis	United States	9
Missouri Cancer Associates	Columbia	United States	17
New York Oncology Hematology, P.C.	Albany	United States	3
New York Oncology Hematology, PC	Rexford	United States	1

Clinical trials